NEWS SUMMARY: CELLNEX, NATURGY. Stock markets pause for a break European stock markets recovered after the strong corrections seen last Friday, fuelled by banks. Thus, in the STOXX 600 most sectors (16/20) ended with gains, led by Banks and Insurance vs. Pharma and Retail that were the worst performers. On the macro side, in the euro zone, August’s Sentix dropped significantly as opposed to expectations following the tariff agreement signed with the US to the worst level since April. In the US,...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX, NATURGY. EUROPA: DHL GROUP. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 2T’25 que se publicarán en España y Europa en los próximos días. Respiro en las bolsas Las bolsas europeas se recuperaron de las fuertes caídas del viernes pasado y rebotaron con el impulso de los bancos. Así, en el STOXX ...
A director at Sacyr S.A. sold 302,864 shares at 3.670EUR and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
2Q'25 vs. 2Q'24 Results Sales: € 2.41 Bn (+0.9% vs. +3.3% BS(e) and +3.8% consensus); EBITDA: € 346.0 M (-0.9% vs. +7.9% BS(e) and +9.2% consensus); EBIT: € 232.0 M (-41.9% vs. -34.3% BS(e) and -32.8% consensus); 1H'25 vs. 1H'24 Results Sales: € 4.469 Bn (+4.7% vs. +6.1% BS(e) and +6.3% consensus); EBITDA: € 655.0 M (+8.6% vs. +13.7% BS(e) and +14.4% consensus); EBIT: € 431.0 M (-21.8% vs. -16.3% BS(e) and -15.2% consensus); Net Profit: € 540.0 M;
Rdos. 2T'25 vs 2T'24: Ventas: 1.178 M euros (+4,7% vs +3,6% BS(e) y +0,7% consenso); EBITDA: 346,0 M euros (+8,9% vs +3,6% BS(e) y +1,3% consenso); EBIT: 221,65 M euros (-28,3% vs -33,1% BS(e) y -34,4% consenso); BDI: 3,52 M euros (-86,8% vs -13,25 M euros BS(e) y -6,0 M euros consenso); Rdos. 1S'25 vs 1S'24: Ventas: 2.237 M euros (+5,6% vs +5,0% BS(e) y +3,4% consenso); EBITDA: 647,0 M euros (-1,5% vs -4,1% BS(e) y -5,2% consenso); EBIT: 463,89 M euros (-22,6% vs -25,1% BS(e) y -25,7% consenso)...
Rdos. 2T'25 vs 2T'24: Ventas: 2.410 M euros (+0,9% vs +3,3% BS(e) y +3,8% consenso); EBITDA: 346,0 M euros (-0,9% vs +7,9% BS(e) y +9,2% consenso); EBIT: 232,0 M euros (-41,9% vs -34,3% BS(e) y -32,8% consenso). Rdos. 1S'25 vs 1S'24: Ventas: 4.469 M euros (+4,7% vs +6,1% BS(e) y +6,3% consenso); EBITDA: 655,0 M euros (+8,6% vs +13,7% BS(e) y +14,4% consenso); EBIT: 431,0 M euros (-21,8% vs -16,3% BS(e) y -15,2% consenso); BDI: 540,0 M euros (n/a vs n/a BS(e) y n/a consenso).
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAIXABANK, FERROVIAL, GRIFOLS, REDEIA, SACYR, SANTANDER, TALGO, TELEFÓNICA. EUROPA: ADIDAS, DANONE, KERING, L’ORÉAL, MERCEDES BENZ GROUP. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 2T’25 que se publicarán en España y Europa en los próximos días. Los resultados toman el relevo Recuperación marcada por el...
NEWS SUMMARY: CAIXABANK, FERROVIAL, GRIFOLS, REDEIA, SACYR, SANTANDER, TALGO, TELEFÓNICA. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 2Q’25 results to be released over the coming days in Spain. Results take centre stage Recovery in Europe in a session marked by the results calendar and news on the trade negotiations of the US with China and the EU. In the STOXX 600, the ral...
2Q'25 vs. 2Q'24: NII: € 374 M (-2.5% vs. -5% BS(e) and -5.3% consensus); Total Revenues: € 543 M (-0.2% vs. -2.5% BS(e) and -3.5% consensus); Operating Income: € 306 M (-4.5% vs. -8.1% BS(e) and -9.5% consensus); Net Profit: € 179 M (-2.5% vs. -8.7% BS(e) and -10.1% consensus). 2Q'25 vs. 1Q'25: NII: € 374 M (+1.5% vs. -1.2% BS(e) and -1.5% consensus); Total Revenues: € 543 M (+5.4% vs. +2.9% BS(e) and +1.9% consensus); Operating Income: € 306 M (+9.1% vs. +4.9% BS(e) and +3.4% consensus); Net Pr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.